An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results

This study aimed to assess the magnitude of anti-SARS-CoV-2 immunoglobulin G (IgG) titers and Interferon-Gamma Release Assay (IGRA) test results following administration of booster BNT162b2 in 48 ChAd-primed participants (vaccination schedule: ChAd/ChAd/BNT). Whole blood samples were collected: firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Zalewska, Marzena, Fus, Wiktoria, Konka, Adam, Wystyrk, Karolina, Bochenek, Aneta, Botor, Hanna, Fronczek, Martyna, Zembala-John, Joanna, Adamek, Brygida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506411/
https://www.ncbi.nlm.nih.gov/pubmed/36146624
http://dx.doi.org/10.3390/vaccines10091546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506411/
https://www.ncbi.nlm.nih.gov/pubmed/36146624
http://dx.doi.org/10.3390/vaccines10091546

Ejemplares similares